Epilepsy Emergency Department High Utilizer Program

by palligoelme@gmail.com | Jun 23, 2026 | Clinical Trials

​ Conditions: Epilepsy; Uncontrolled Seizures Interventions: Behavioral: CHW-Led Transition-of-Care Intervention Sponsors: Morehouse School of Medicine; Grady Health System; Emory University; UCB Pharma; Epilepsy Foundation; NYU Langone Health Enrolling by...

A Study of Food Effect on Tersolisib (LY4064809) in Healthy Participants

by palligoelme@gmail.com | Jun 23, 2026 | Clinical Trials

​ Conditions: Healthy Interventions: Drug: Tersolisib; Other: High-fat Meal; Other: Low-fat Meal Sponsors: Eli Lilly and Company Not yet recruiting Conditions: Healthy Interventions: Drug: Tersolisib; Other: High-fat Meal; Other: Low-fat Meal Sponsors: Eli Lilly and...

Antireflux Surgery Without Preoperative Esophageal Manometry

by palligoelme@gmail.com | Jun 22, 2026 | Clinical Trials

​ Conditions: GERD; Hiatal Hernia; Heartburn; Paraesophageal Hernia; Gastroesophageal Reflux Interventions: Procedure: Preoperative workup without high-resolution esophageal manometry; Procedure: Standard preoperative workup with high-resolution esophageal manometry...

Parental Distress and Treatment Adherence in Pediatric Recurrent Medulloblastoma

by palligoelme@gmail.com | Jun 22, 2026 | Clinical Trials

​ Conditions: Medulloblastoma; Recurrent Medulloblastoma Interventions: Other: Not applicable- observational study Sponsors: West China Hospital; First Affiliated Hospital Xi’an Jiaotong University; Shanghai Children’s Medical Center; Children’s...

A Phase 2 Study of VS-7375 in Patients With KRAS G12D-Mutated Non-Small Cell Lung Cancer

by palligoelme@gmail.com | Jun 22, 2026 | Clinical Trials

​ Conditions: Non-Small Cell Lung Cancer Interventions: Drug: VS-7375 Sponsors: Verastem, Inc. Not yet recruiting Conditions: Non-Small Cell Lung Cancer Interventions: Drug: VS-7375 Sponsors: Verastem, Inc. Not yet...

Optimizing Ancillary Therapies With Immune Checkpoint Inhibitors for Solid Tumors (OAT ICI)

by palligoelme@gmail.com | Jun 22, 2026 | Clinical Trials

​ Conditions: Solid Tumors Interventions: Drug: Asprin; Drug: Loratadine; Behavioral: Acetaminophen Avoidance; Behavioral: THC Avoidance Sponsors: Val Adams Not yet recruiting Conditions: Solid Tumors Interventions: Drug: Asprin; Drug: Loratadine; Behavioral:...